Retina en felinos

47
Enfermedades de la retina Felina 11° Simposio Platense de Medicina Veterinaria Pablo Sande, MV, PhD, DCLOVE [email protected] www.veteoftalmo.com.ar

description

 

Transcript of Retina en felinos

Page 1: Retina en felinos

Enfermedades de la retina Felina

11° Simposio Platense de Medicina Veterinaria

Pablo Sande, MV, PhD, DCLOVE [email protected]

www.veteoftalmo.com.ar

Page 2: Retina en felinos

Esquema de la retina

Page 3: Retina en felinos

Normal

Atrofia

Inflamación

Vaso

s Coro

ideo

sVa

sos

Ret

inia

nos

Page 4: Retina en felinos

Retina Normal

Page 5: Retina en felinos
Page 6: Retina en felinos

Examen del fondo del ojo

Page 7: Retina en felinos

Directo

PanopticoIndirecto

Page 8: Retina en felinos

Métodos complementarios

!Guidelines for clinical electroretinography in the dog KRISTINA NARFSTRÖM1, BJÖRN EKESTEN2, SERGE G. ROSOLEN3,B ERNHARD M. SPIESS4, CHRISTINE L. PERCICOT5 and RON OFRI6, Documenta Ophthalmologica 105: 83–92, 2002.

ERG

Mixto

ConosPot. Osc.

Page 9: Retina en felinos

Métodos complementariosRFG

Page 10: Retina en felinos

RFG

ERG

Orác

ulo

Ecógrafo

Page 11: Retina en felinos

Hereditarias

Nutricionales

Vasculares

Inflamatorias

Tóxicas

Page 12: Retina en felinos

Degeneraciones Hereditarias, Atrofia progresiva de la Retina

# Ceguera progresiva, primero nocturna, luego diurna, desde periferia al centro

!- - - - - - - - - - - - - - - - - - - - - - !APR esta probada en el Gato Abisinio !Barnett y Carlise la describieron en

siameses !Rubin y Lipton la describieron en Persas !Buyukmichi en gatos mestizos

Page 13: Retina en felinos

Functional Assessment of the Regional Distribution of Disease in a Cat Model of Hereditary Retinal Degeneration Mathias W. Seeliger1 and Kristina Narfstro¨m2

Page 14: Retina en felinos
Page 15: Retina en felinos

Atrofia progresiva de la Retina, Electrorretinografia

Page 16: Retina en felinos
Page 17: Retina en felinos

Nutricionales, Deficiencia de Taurina

# Aminoácido esencial en los felinos !# 10mg/kg de requerimiento diario !# Mayor concentración en retina y corazón !# Incluidos en los A. Balanceados

Page 18: Retina en felinos
Page 19: Retina en felinos

Imágenes angiograficas

Page 20: Retina en felinos

Imágenes angiograficas

Page 21: Retina en felinos

Pot. Oscilatorios

F. Blanco

   Flicker

F. Azul

Electrorretinografia

Page 22: Retina en felinos

# Las lesiones reflejadas en el ERG comienzan a

las 10 semanas !

# Las lesiones oftalmoscopicas

comienzan entre los 3 y 7 meses

!# La ceguera completa se

hace evidente 9 a 10 meses

Nutricionales, Deficiencia de Taurina

Page 24: Retina en felinos

Spontaneous feline hypertension: clinical and echocardiographic abnormalities, and survival rate. Chetboul V, Lefebvre HP, Pinhas C, Clerc B, Boussouf M, Pouchelon JL. J Vet Intern Med. 2003 Jan-Feb;17(1):89-95.

Hypertensive retinopathy and choroidopathy in a cat. Komáromy AM, Andrew SE, Denis HM, Brooks DE, Gelatt KN. Vet Ophthalmol. 2004 Jan-Feb;7(1):3-9.

Prevalencia de lesiones retinianas en gatos con hipertensión: 48%

!262 +/- 34 mmhg con retinopatía

!221 +/- 34 mmhg sin retinopatía

Vasculares, Retinopatia Hipertensiva

Page 25: Retina en felinos

Imagenes angiograficas

Page 26: Retina en felinos

Vasculares, Retinopatia Hipertensiva

Page 27: Retina en felinos
Page 28: Retina en felinos
Page 29: Retina en felinos

# Daño vascular con perdida de plasma y células

!# Hemorragias en retina y vítreo,

desprendimientos de retina !

# Droga de elección: Amlodipina 0.625 a 1,25mg día

Vasculares, Retinopatia Hipertensiva

Page 30: Retina en felinos

Signos en el Segmento Anterior

Page 31: Retina en felinos

“Reconocer a los gatos en riesgo es importante a la hora de conservar la visión”

Page 32: Retina en felinos

Inflamatorias, coroideoretinitis

# Focales

# Difusas

# Multifocales

Page 33: Retina en felinos

Barrera Hemato-retiniana

BHO (Interna)

BHO (Externa)

Page 34: Retina en felinos

identified rapid microglial process extension upon injection ofATP11. Fibrinogen is a novel molecular signal that can mediate asimilar response. ATP mediates microglial responses throughthe P2Y12 receptor44. As rapid microglial process extension isassociated with dramatic cytoskeletal rearrangements, presumablyinvolving activation of the Rho signaling pathway, cross-talk ofP2Y12 with integrin receptors might mediate the rapid microglialresponse induced by fibrinogen. Indeed, integrins are primarily

responsible for cytoskeletal rearrangements, and fibrinogeninduces Rho activation in microglia via CD11b/CD18 (ref. 27).ATP induces integrin-b1 expression in microglia through P2Y12receptor and integrin-b1 activation is involved in the directionalprocess extension by microglia in brain tissue45. Moreover, ATPincreases CD11b expression in microglia46 and eosinophils47.Future studies will determine the potential cross-talk betweenP2Y12 and microglial integrin receptors upon BBB disruption.

a

b Healthy Pre-onset EAE Peak EAE

Pial macrophage

Fibrinogen

Axon

ROS

Microglia

Basal membrane

0

20

40

60

Cx3cr1GFP/+

Fib+/+

Cx3cr1GFP/+

Fib+/+

Cx3cr1GFP/+

Fib!390-396Α

Cx3cr1GFP/+

Fib!390-396Α

Clu

ster

s pe

r 0.5

mm

3 *Cx3cr1GFP/+Fib+/+ Cx3cr1GFP/+Fib!390-396A

Peak EAE

Cx3

cr1G

FP

/+ /

Rho

dam

ine

dext

ran

0

0.5

1

1.5

2

2.5 *

SM

I-32

(%

are

a)

SM

I-32

/D

AP

I

Figure 8 | Fibrinogen mediates perivascular microglial clustering and axonal damage via CD11b/CD18. (a) In vivo imaging of Cx3cr1GFP/þFibg390-396A

mice at the peak of EAE (n¼6) shows fewer perivascular clusters (top) and significantly less SMI-32 immunoreactivity (bottom) than in Cx3cr1GFP/þ

Fibþ /þ controls (n¼9). Correlated histology was performed in the same spinal cord areas in the mice that were previously imaged in vivo. Values aremean±s.e.m. *Po0.05 (Mann–Whitney test). Scale bars, top: 10mm; bottom: 50mm. (b) Schematic illustration and working model of the dynamicresponses of perivascular microglia and pial macrophages to BBB disruption and their contribution to axonal damage in neuroinflammatory disease. In thehealthy CNS, microglia are evenly distributed and stochastically extend and retract their processes. In EAE mice before the onset of neurological symptomsfibrinogen leaks in the CNS, triggering microglial process extension and cell body accumulation toward the vasculature. At the peak of disease, microglialclustering around the vasculature occurs almost exclusively in areas of fibrin deposition and is associated with axonal damage and release of ROS bymicroglia. Fibrinogen signaling via the CD11b/CD18 integrin receptor is required for the formation of perivascular clusters and the development of axonaldamage.

NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2230 ARTICLE

NATURE COMMUNICATIONS | 3:1227 | DOI: 10.1038/ncomms2230 | www.nature.com/naturecommunications 11

& 2012 Macmillan Publishers Limited. All rights reserved.

identified rapid microglial process extension upon injection ofATP11. Fibrinogen is a novel molecular signal that can mediate asimilar response. ATP mediates microglial responses throughthe P2Y12 receptor44. As rapid microglial process extension isassociated with dramatic cytoskeletal rearrangements, presumablyinvolving activation of the Rho signaling pathway, cross-talk ofP2Y12 with integrin receptors might mediate the rapid microglialresponse induced by fibrinogen. Indeed, integrins are primarily

responsible for cytoskeletal rearrangements, and fibrinogeninduces Rho activation in microglia via CD11b/CD18 (ref. 27).ATP induces integrin-b1 expression in microglia through P2Y12receptor and integrin-b1 activation is involved in the directionalprocess extension by microglia in brain tissue45. Moreover, ATPincreases CD11b expression in microglia46 and eosinophils47.Future studies will determine the potential cross-talk betweenP2Y12 and microglial integrin receptors upon BBB disruption.

a

b Healthy Pre-onset EAE Peak EAE

Pial macrophage

Fibrinogen

Axon

ROS

Microglia

Basal membrane

0

20

40

60

Cx3cr1GFP/+

Fib+/+

Cx3cr1GFP/+

Fib+/+

Cx3cr1GFP/+

Fib!390-396Α

Cx3cr1GFP/+

Fib!390-396Α

Clu

ster

s pe

r 0.5

mm

3 *Cx3cr1GFP/+Fib+/+ Cx3cr1GFP/+Fib!390-396A

Peak EAE

Cx3

cr1G

FP

/+ /

Rho

dam

ine

dext

ran

0

0.5

1

1.5

2

2.5 *

SM

I-32

(%

are

a)

SM

I-32

/D

AP

I

Figure 8 | Fibrinogen mediates perivascular microglial clustering and axonal damage via CD11b/CD18. (a) In vivo imaging of Cx3cr1GFP/þFibg390-396A

mice at the peak of EAE (n¼6) shows fewer perivascular clusters (top) and significantly less SMI-32 immunoreactivity (bottom) than in Cx3cr1GFP/þ

Fibþ /þ controls (n¼9). Correlated histology was performed in the same spinal cord areas in the mice that were previously imaged in vivo. Values aremean±s.e.m. *Po0.05 (Mann–Whitney test). Scale bars, top: 10mm; bottom: 50mm. (b) Schematic illustration and working model of the dynamicresponses of perivascular microglia and pial macrophages to BBB disruption and their contribution to axonal damage in neuroinflammatory disease. In thehealthy CNS, microglia are evenly distributed and stochastically extend and retract their processes. In EAE mice before the onset of neurological symptomsfibrinogen leaks in the CNS, triggering microglial process extension and cell body accumulation toward the vasculature. At the peak of disease, microglialclustering around the vasculature occurs almost exclusively in areas of fibrin deposition and is associated with axonal damage and release of ROS bymicroglia. Fibrinogen signaling via the CD11b/CD18 integrin receptor is required for the formation of perivascular clusters and the development of axonaldamage.

NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2230 ARTICLE

NATURE COMMUNICATIONS | 3:1227 | DOI: 10.1038/ncomms2230 | www.nature.com/naturecommunications 11

& 2012 Macmillan Publishers Limited. All rights reserved.

F i g u re 8 | F i b r i no g e n m e d i at e s perivascular microglial clustering and axonal damage via CD11b/CD18

(b) Schematic illustration and working model of the dynamic responses of p e r i va s cu lar m i cro g l i a and p i al macrophages to BBB disruption and their contr ibution to axonal damage in neuroinflammatory disease. In the healthy CNS, microglia are evenly distributed and stochastically extend and retract their processes. In EAE mice before the onset of neurological symptoms fibrinogen leaks in the CNS, triggering microglial p roce s s ex tens ion and ce l l bo dy accumulation toward the vasculature. At the peak of disease, microglial clustering around the vasculature occurs almost exclusively in areas of fibrin deposition and is associated with axonal damage and release of ROS by microg l ia . Fibrinogen signaling via the CD11b/CD18 integrin receptor is required for the formation of perivascular clusters and the development of axonal damage.

# Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation

Dimitrios Davalos1, Jae Kyu Ryu1, Mario Merlini1, Kim M. Baeten1, Natacha Le Moan1,w, Mark A. Petersen1,2, Thomas J. Deerinck3,4, Dimitri S.

Smirnoff1, Catherine Bedard1, Hiroyuki Hakozaki4, Sara Gonias Murray1, Jennie B. Ling1, Hans Lassmann5, Jay L. Degen6, Mark H.

Ellisman3,4 & Katerina Akassoglou1,7

Inflamatorias, coroideoretinitis

NATURE COMMUNICATIONS

Page 35: Retina en felinos
Page 36: Retina en felinos

Causas mas frecuentes de Coriorretinitis

1. Infecciosas (Virales)

2. Micosis

3. Traumatismos !4. Neoplasias

PIF ViLeF ViF

Parasitaria

Vimos

un

Cripto

coco!!!

5.

ToxoplasmosisRaro!

Page 37: Retina en felinos

Inflamatorias, Toxoplasmosis

Toxoplasma gondii (for a review, see Dubey, 2004). )

Page 38: Retina en felinos

Inflamatorias, Criptococosis

Cryptococcus neoformans or Cryptococcus gattii (previously C. neoformans var gattii) (Wolf, 1989).

# Uveitis granulomatosa # Desprendimiento de retina # Neuritis optica

Page 39: Retina en felinos

Inflamatorias, PIF

Page 40: Retina en felinos

Inflamatorias, VIF

Page 41: Retina en felinos

Inflamatorias, ViLeF

Page 42: Retina en felinos

Toxicas, Secundarias a Quinolonas y algo mas……

Factores de Riesgo: !

# Edad del paciente ! # Renopatías , hepatopatías ! # Dosis, duración y vías de administración

# Retinal toxicity of liposome-incorporated and free ofloxacin after intravitreal injection in rabbit eyes. Wiechens B, Neumann D, Grammer JB, Pleyer U, Hedderich J, Duncker GI. Int Ophthalmol. 1998-1999;22(3):133-43.

# Fluoroquinolone-induced retinal degeneration in cats. Wiebe V, Hamilton P. J Am Vet Med Assoc. 2002 Dec 1;221(11):1568-71. Review

Page 43: Retina en felinos

Quinolonas, Características Histopatólogicas

# Vacuolas citoplasmáticas !# Degeneración primaria de los conos !# Edema !# en la fase crónica ha y deg en e rac i ón c o m p l e t a d e l o s fotorreceptores

Page 44: Retina en felinos

Quinolonas, Bases genéticas

(Ramirez et al., 2011)

# Alteración de la proteína ABCG2 de la Barrera Hemato-

Ocular !

# Acumulación de la Quinolona en la retina

!

# Formación de ROS y Daño retiniano

Page 45: Retina en felinos

Electrorretinografía

Page 46: Retina en felinos

Tóxicas, Secundarias a Quinolonas y algo mas……

# Griseofulvina

# Ivermectina

# Acetato de Megestrol

Degeneración súbita de fotorreceptores, supresión de la medula ósea y muerte (Rottman et al., 1991)

# signos neurológicos, ceguera c/an i socor ia , m idr ia s i s o m io s i s (Houston, 1985; Lewis et al., 1994).

# R e t i n i t i s h e m o r r á g i c a , Desprendimiento de retina (Bedford & Cotchin, 1983; Kunkle, 1984; Spiess et al., 1991)

Page 47: Retina en felinos

Muchas Gracias!!!!

Pablo Sande, MV, PhD, DCLOVE [email protected]

www.veteoftalmo.com.ar